Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Stasi

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|April 6, 2005
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpuraRoberto Stasi, Zaccaria Rossi, Elisa Stipa, et al.
Thrombosis and Haemostasis|January 25, 2008
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and managementRoberto Stasi, Maria Laura Evangelista, Elisa Stipa, et al.
AJR. American Journal of Roentgenology|November 22, 2012
Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor locationGiampiero Francica, Alessandra Petrolati, Enrico Di Stasio, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 7, 2012
Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablationGiampiero Francica, Alesssandra Petrolati, Enrico Di Stasio, et al.
Haematologica|December 7, 2007
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adultsDrew Provan, Tom Butler, Maria Laura Evangelista, et al.
The Oncologist|August 5, 2005
Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concernsRoberto Stasi, Sergio Amadori, Timothy J Littlewood, et al.
International Journal of Hematology|July 18, 2009
High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patientsTommaso Caravita, Agostina Siniscalchi, Marco Montanaro, et al.
British Journal of Haematology|July 11, 2012
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopeniaNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
Blood Reviews|May 25, 2010
Thrombopoietic agentsRoberto Stasi, Jenny Bosworth, Elizabeth Rhodes, et al.
European Journal of Radiology|May 15, 2007
Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinomaClaudio M Pacella, Roberto Stasi, Giancarlo Bizzarri, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|April 6, 2005
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpuraRoberto Stasi, Zaccaria Rossi, Elisa Stipa, et al.
Thrombosis and Haemostasis|January 25, 2008
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and managementRoberto Stasi, Maria Laura Evangelista, Elisa Stipa, et al.
AJR. American Journal of Roentgenology|November 22, 2012
Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor locationGiampiero Francica, Alessandra Petrolati, Enrico Di Stasio, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 7, 2012
Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablationGiampiero Francica, Alesssandra Petrolati, Enrico Di Stasio, et al.
Haematologica|December 7, 2007
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adultsDrew Provan, Tom Butler, Maria Laura Evangelista, et al.
The Oncologist|August 5, 2005
Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concernsRoberto Stasi, Sergio Amadori, Timothy J Littlewood, et al.
International Journal of Hematology|July 18, 2009
High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patientsTommaso Caravita, Agostina Siniscalchi, Marco Montanaro, et al.
British Journal of Haematology|July 11, 2012
Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopeniaNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
Blood Reviews|May 25, 2010
Thrombopoietic agentsRoberto Stasi, Jenny Bosworth, Elizabeth Rhodes, et al.
European Journal of Radiology|May 15, 2007
Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinomaClaudio M Pacella, Roberto Stasi, Giancarlo Bizzarri, et al.
Pageof 9